Enicepatide Clinical Trials (2026): 4 Studies for Obesity or Overweight & Obesity
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
4 Enicepatide clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 3 indications (including Obesity or Overweight & Obesity) and 4,429 total planned enrollment. 2 Phase 3 Enicepatide trials and 2 Phase 2 are listed. 2 Enicepatide clinical trials are actively recruiting at 53 U.S. sites across 26 states. Most recent activity: NCT07351045 (Aug 2028).
Where to Participate: All Enicepatide Trial Sites in the U.S. (53 sites across 26 states)
Every actively recruiting Enicepatidetrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AL | Pinnacle Research Group | Anniston36207 | NCT07351045 | Map |
| AL | Alabama Clinical Therapeutics | Birmingham35235 | NCT07351045 | Map |
| AL | University of Alabama at Birmingham | Birmingham35294-3360 | NCT07351045 | Map |
| AL | Lakeview Clinical Research | Guntersville35976 | NCT07351058 | Map |
| AZ | Arizona Clinical Trials | Tucson85711 | NCT07351045 | Map |
| AZ | Arizona Clinical Trials | Tucson85711 | NCT07351058 | Map |
| CA | Orange County Research Center | Lake Forest92630 | NCT07351058 | Map |
| CA | Ark Clinical Research | Long Beach90815 | NCT07351058 | Map |
| CA | Catalina Research Institute, LLC | Montclair91763 | NCT07351058 | Map |
| CA | Prospective Research Innovations Inc. | Rancho Cucamonga91730 | NCT07351058 | Map |
| CA | Artemis Institute for Clinical Research, LLC | San Diego92123 | NCT07351045 | Map |
| CA | Encompass Clinical Research | Spring Valley91978 | NCT07351058 | Map |
| DC | Emerson Clinical Research Institute | Washington D.C.20009 | NCT07351058 | Map |
| FL | Tampa Bay Medical Research, Inc. | Clearwater33761 | NCT07351058 | Map |
| FL | Center for Diabetes, Obesity and Metabolism Inc | Pembroke Pines33024 | NCT07351058 | Map |
| FL | Progressive Medical Research | Port Orange32127 | NCT07351058 | Map |
| FL | Eirvera, LLC | St. Petersburg33711 | NCT07351058 | Map |
| GA | Centricity Research Columbus Georgia Multispecialty | Columbus31904 | NCT07351058 | Map |
| GA | Rophe Adult and Pediatric Medicine/SKYCRNG | Union City30291 | NCT07351045 | Map |
| GA | Rophe Adult and Pediatric Medicine/SKYCRNG | Union City30291 | NCT07351058 | Map |
| HI | East-West Medical Research Institute | Honolulu96814 | NCT07351045 | Map |
| IL | Elevate Clinical Research | Gurnee60031 | NCT07351045 | Map |
| IL | Knownwell | Schaumburg60194 | NCT07351045 | Map |
| KY | Monroe Biomedical Research | Louisville40213 | NCT07351045 | Map |
| LA | Elevate Clinical Research | Lake Charles70605 | NCT07351058 | Map |
| MD | Centennial Medical Group | Columbia21045-5840 | NCT07351058 | Map |
| MA | Knownwell | Needham02492 | NCT07351045 | Map |
| MN | International Diabetes Center At Park Nicollet | Minneapolis55416 | NCT07351045 | Map |
| MO | Clinvest Research LLC | Springfield65807 | NCT07351045 | Map |
| NY | Rochester Clinical Research | Buffalo14217 | NCT07351045 | Map |
| NC | Centricity Research Morehead City Multispeciality | Morehead City28557 | NCT07351058 | Map |
| OH | Remington Davis Inc | Columbus43215 | NCT07351058 | Map |
| OH | Hometown Urgent Care and Research - Dayton | Dayton45424 | NCT07351045 | Map |
| OK | Essential Medical Research | Tulsa74137 | NCT07351058 | Map |
| OR | Headlands Reseach- Summit | Portland97210 | NCT07351045 | Map |
| PA | Suburban Research Associates - West Chester Office | West Chester19380 | NCT07351045 | Map |
| SC | Trial Management Associates | Myrtle Beach29572 | NCT07351045 | Map |
| SC | Coastal Carolina Research Center | North Charleston29405 | NCT07351058 | Map |
| SD | Circle Clinical Research | Sioux Falls57104 | NCT07351045 | Map |
| SD | Circle Clinical Research | Sioux Falls57104 | NCT07351058 | Map |
| TN | Innovative Clinical Research | Clarksville37040 | NCT07351045 | Map |
| TN | Clinical Research Associates | Nashville37203 | NCT07351045 | Map |
| TX | Bellaire Clinical Research, LLC | Bellaire77401 | NCT07351045 | Map |
| TX | University of Texas Southwestern Medical Center - Children's Medical Center Dallas | Dallas75390 | NCT07351045 | Map |
| TX | Velocity Clinical Research | Dallas75230 | NCT07351058 | Map |
| TX | Elevate Clinical | Houston77058 | NCT07351045 | Map |
| TX | Juno Research, LLC | Houston77040 | NCT07351058 | Map |
| TX | Elevate Clinical | McAllen78504 | NCT07351045 | Map |
| TX | HRI ? Pasadena, LLC | Pasadena77505 | NCT07351058 | Map |
| TX | DM Clinical Research | Tomball77375 | NCT07351058 | Map |
| VA | Manassas Clinical Research Center | Manassas20110 | NCT07351058 | Map |
| VA | Centricity Research Suffolk Primary Care | Suffolk23435 | NCT07351058 | Map |
| WA | Era Health Research | Redmond98052 | NCT07351058 | Map |
Enicepatide clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | completed | Total |
|---|---|---|---|---|
| P2 | 1 | 1 | 2 | |
| P3 | 2 | 2 |
Recruiting Enicepatide clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07351045 | Enith1A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes | P3 | Obesity or Overweight | 2,000 | Mar 2026 |
| NCT07351058 | Enith2A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes | P3 | Obesity or Overweight | 1,600 | Mar 2026 |
Enicepatide clinical trials by indication
Obesity or Overweight (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07351045 | Enith1 | P3 | recruiting | A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes |
| NCT07351058 | Enith2 | P3 | recruiting | A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes |
Overweight or Obese (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06628362 | CT-388 | P2 | active not recruiting | A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus |
Obesity (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06525935 | CT-388 | P2 | completed | A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity |
Enicepatide pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| Enith1 | NCT07351045 | P3 | recruiting | Obesity or Overweight | 2,000 | — |
| Enith2 | NCT07351058 | P3 | recruiting | Obesity or Overweight | 1,600 | — |
| CT-388 | NCT06628362 | P2 | active not recruiting | Overweight or Obese | 360 | — |
| CT-388 | NCT06525935 | P2 | completed | Obesity | 469 | — |
All Enicepatide trials (4)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07351045 | Enith1 | A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes | P3 | recruiting | 2,000 | Hoffmann-La Roche | Mar 2026 |
| NCT07351058 | Enith2 | A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes | P3 | recruiting | 1,600 | Hoffmann-La Roche | Mar 2026 |
| NCT06628362 | CT-388 | A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus | P2 | active not recruiting | 360 | Carmot Therapeutics, Inc. | Nov 2024 |
| NCT06525935 | CT-388 | A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity | P2 | completed | 469 | Carmot Therapeutics, Inc. | Aug 2024 |
Enicepatide clinical trials: frequently asked questions
- How many Enicepatide clinical trials are there?
- 4 Enicepatide clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants. 1 is marked completed.
- Are Enicepatide clinical trials recruiting in 2026?
- Yes — 2 Enicepatide trials are actively recruiting in 2026, with 53 U.S. sites across 26 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Enicepatide being studied for?
- Enicepatide is being studied for Obesity or Overweight, Obesity, Overweight, Overweight or Obese, Type 2 Diabetes Mellitus and 1 more. The trials are grouped by indication on this page.
- What phase is Enicepatide in?
- Enicepatide clinical trials span 2 Phase 3, 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Enicepatide clinical trials?
- The lead sponsor across the most Enicepatide trials is Carmot Therapeutics, Inc., with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Enicepatideas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: